United States · FDA National Drug Code directory
naproxen sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69452-259_51a1be90-a17c-8e7f-e063-6394a90a1cb0
- Product NDC
- 69452-259
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- naproxen sodium
- Labeler
- Bionpharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190802
- Source listing expiry
- 20271231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (69452-259-21) · 69452-259-21
- 180 CAPSULE, LIQUID FILLED in 1 BOTTLE (69452-259-25) · 69452-259-25
- 1 BOTTLE in 1 CARTON (69452-259-78) / 80 CAPSULE, LIQUID FILLED in 1 BOTTLE · 69452-259-78
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →